News
SFOSF
2.700
NaN%
--
Fosun Pharma Subsidiary Wins NMPA Nod for Dual-Target CAR-T Trial
TipRanks · 15h ago
Weekly Report: what happened at SFOSF last week (0406-0410)?
Weekly Report · 1d ago
Fosun Pharma Subsidiary Wins China Nod for Flurbiprofen Pain Injection
TipRanks · 4d ago
Fosun Pharma Sets April Board Meeting to Approve First-Quarter 2026 Results
TipRanks · 4d ago
Citic Securities Sticks to Its Buy Rating for Shanghai Fosun Pharmaceutical (Group) Co (SFOSF)
TipRanks · 5d ago
Weekly Report: what happened at SFOSF last week (0330-0403)?
Weekly Report · 04/06 09:54
Fosun Pharma Wins China Trial Nod for Teva-Partnered Cancer Drug FXB0871
TipRanks · 03/31 12:04
Weekly Report: what happened at SFOSF last week (0323-0327)?
Weekly Report · 03/30 09:55
Citi Keeps Their Buy Rating on Shanghai Fosun Pharmaceutical (Group) Co (SFOSF)
TipRanks · 03/28 00:53
Fosun Pharma Lifts 2025 Profit on Higher Margins and EBITDA
TipRanks · 03/24 22:40
Fosun Pharma Proposes 2025 Final Dividend and Details Tax Treatment for H-Share Investors
TipRanks · 03/24 22:40
Weekly Report: what happened at SFOSF last week (0316-0320)?
Weekly Report · 03/23 09:52
Fosun Pharma Subsidiary Wins Approval for Sodium Thiosulfate Antidote Injection
TipRanks · 03/20 11:09
Fosun Pharma Unit Wins China Trial Nod for Novel Alopecia Biotherapeutic
TipRanks · 03/16 11:13
Weekly Report: what happened at SFOSF last week (0309-0313)?
Weekly Report · 03/16 09:51
Fosun Pharma Wins NMPA Nod to Start Trials of New Blood Cancer Drug FXS0683
TipRanks · 03/13 10:09
Weekly Report: what happened at SFOSF last week (0302-0306)?
Weekly Report · 03/09 09:52
Fosun Pharma Sets March 2026 Board Meeting to Approve 2025 Results and Dividend Plan
TipRanks · 03/09 09:41
Weekly Report: what happened at SFOSF last week (0223-0227)?
Weekly Report · 03/02 09:52
Fosun Pharma Reports Strong Shareholder Turnout at 2026 Extraordinary Meetings
TipRanks · 02/27 15:28
More
Webull provides a variety of real-time SFOSF stock news. You can receive the latest news about Shanghai Fosun Pharmaceutical through multiple platforms. This information may help you make smarter investment decisions.
About SFOSF
Shanghai Fosun Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company operates in five segments. Pharmaceutical segment is mainly engaged in the manufacturing of innovative drugs, mature pharmaceutical products and vaccines. Medical Devices and Medical Diagnostics segment is mainly engaged in the manufacturing and sales of medical cosmetic devices such as molecular diagnosis, immunodiagnosis, and microbial diagnosis. Medical Health Services segment is mainly engaged in the operation of an online and offline integrated medical service platform. Pharmaceutical Distribution and Retail segment is mainly engaged in the wholesale and retail of pharmaceutical products. Others segment is engaged in other pharmaceutical-related businesses. The Company's products are mainly used in the treatment of tumors, immunity, central nervous system and other fields.